4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001415889-24-001313
CHIEF EXECUTIVE OFFICER acquired 240,530 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/form4-01172024_090120.xml…